296 related articles for article (PubMed ID: 8769224)
1. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
2. Potential role of Neoral in pediatric liver transplantation.
Whitington PF; Alonso EM; Millis JM
Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
[No Abstract] [Full Text] [Related]
3. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
4. Neoral in liver transplantation.
Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
[No Abstract] [Full Text] [Related]
5. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
[TBL] [Abstract][Full Text] [Related]
6. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
7. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
8. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
[No Abstract] [Full Text] [Related]
9. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
10. Follow-up after conversion to Neoral in stable heart transplant recipients.
Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T
Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
[No Abstract] [Full Text] [Related]
11. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
12. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
Jain A
Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
Cooney GF; Lum BL; Meligeni JA; Dunn SP
Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
[No Abstract] [Full Text] [Related]
14. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
15. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
Roth D; Miller J
Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
[No Abstract] [Full Text] [Related]
16. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
[No Abstract] [Full Text] [Related]
17. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
[No Abstract] [Full Text] [Related]
18. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
[No Abstract] [Full Text] [Related]
19. Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation.
Hashikura Y; Kawasaki S; Matsunami H; Terada M; Ikegami T; Nakazawa Y; Watanabe M; Chisuwa H; Kamijima T; Takagi S; Makuuchi M
Transplant Proc; 1996 Apr; 28(2):1034-5. PubMed ID: 8623218
[No Abstract] [Full Text] [Related]
20. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
Rolles K; Davidson BR; Burroughs AK
Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]